"Designing Growth Strategies is in our DNA"

Sickle Cell Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Treatment Modality [Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy {Hydroxyurea, and Branded Products (Endari, Adakveo, Oxbryta, Zynteglo, PYRUKYND (Mitapivat), CTX001, Inclacumab, MGTA-145, Vamifeport (VIT-2763), ALXN1820, FT-4202, and GBT021601)}], By End-user [Hospitals, Specialty Clinics, and Others], and Regional Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101009

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Sickle Cell Disease, For Key Countries/ Regions, 2022
    2. Overview – Branded Drugs (Marketed)
    3. Pipeline Analysis, Key Players
    4. New Product Launches
    5. Key Industry Developments (Mergers, Acquisitions, Partnership; etc.)
    6. Impact of COVID-19 on the Market
  5. Global Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
          12. GBT021601
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Region
      1. U.S.
      2. Europe
      3. Rest of the World
  6. U.S. Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
          12. GBT021601
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  7. Europe Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
          12. GBT021601
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  8. Rest of the World Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
          12. GBT021601
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  9. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. Bristol-Myers Squibb Company
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Addmedica
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Novartis AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Global Blood Therapeutics, Inc. (Pfizer Inc.)
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Emmaus Medical, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. bluebird bio Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Agios Pharmaceuticals, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 01: Global Sickle Cell Disease Treatment Market Revenue Breakdown (USD billion, %) by Geography, 2022 & 2030

Figure 02: Global Sickle Cell Disease Treatment Market Value Share (%), By Treatment Modality, 2022 & 2030

Figure 03: Global Sickle Cell Disease Treatment Market Value Share (%), By End-user, 2022 & 2030

Figure 04: Global Sickle Cell Disease Treatment Market Value Share (%), By Geography, 2022 & 2030

Figure 05: U.S. Sickle Cell Disease Treatment Market Value (USD billion), by Treatment Modality, 2022 & 2030

Figure 06: U.S. Sickle Cell Disease Treatment Market Value Share (%), by Treatment Modality, 2022

Figure 07: U.S. Sickle Cell Disease Treatment Market Value (USD billion), by End-user, 2022 & 2030

Figure 08: U.S. Sickle Cell Disease Treatment Market Value Share (%), by End-user, 2022

Figure 09: Europe Sickle Cell Disease Treatment Market Value (USD billion), by Treatment Modality, 2022 & 2030

Figure 10: Europe Sickle Cell Disease Treatment Market Value Share (%), by Treatment Modality, 2022

Figure 11: Europe Sickle Cell Disease Treatment Market Value (USD billion), by End-user, 2022 & 2030

Figure 12: Europe Sickle Cell Disease Treatment Market Value Share (%), by End-user, 2022

Figure 13: Rest of the World Sickle Cell Disease Treatment Market Value (USD billion), by Treatment Modality, 2022 & 2030

Figure 14: Rest of the World Sickle Cell Disease Treatment Market Value Share (%), by Treatment Modality, 2022

Figure 15: Rest of the World Sickle Cell Disease Treatment Market Value (USD billion), by End-user, 2022 & 2030

Figure 16: Rest of the World Sickle Cell Disease Treatment Market Value Share (%), by End-user, 2022

Figure 17: Global Sickle Cell Disease Treatment Market Share (%), by Company, 2022

Table 01: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2019–2030

Table 02: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2019–2030

Table 03: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2019–2030

Table 04: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2019–2030

Table 05: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Geography, 2019–2030

Table 06: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2019–2030

Table 07: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2019–2030

Table 08: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2019–2030

Table 09: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2019–2030

Table 10: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2019–2030

Table 11: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2019–2030

Table 12: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2019–2030

Table 13: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2019–2030

Table 14: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2019–2030

Table 15: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2019–2030

Table 16: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2019–2030

Table 17: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2019–2030

Sickle Cell Disease Treatment Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 103
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase